Drug Shortage Report for SANDOZ RABEPRAZOLE
Report ID | 110044 |
Drug Identification Number | 02314177 |
Brand name | SANDOZ RABEPRAZOLE |
Common or Proper name | RABEPRAZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-03-16 |
Estimated end date | 2020-05-15 |
Actual end date | 2020-05-15 |
Shortage status | Resolved |
Updated date | 2020-05-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-05-19 | French | Compare |
v3 | 2020-05-19 | English | Compare |
v2 | 2020-03-30 | French | Compare |
v1 | 2020-03-30 | English | Compare |
Showing 1 to 4 of 4